CNMV - Inside information

This website uses its own cookies and third-party cookies for technical, customisation, and analysis of behavioural advertising purposes. The latter provides data regarding browsing habits (such as the pages visited) and determine profiles to improve our content.

For further information, please read our Cookies Policy

This website contains links from third-party websites that may contain cookies not belonging to the CNMV. By viewing and accessing them, you accept the cookies installed by third parties and their corresponding privacy and cookies policy.

This website uses cookies and/or similar technologies that store and retrieve information when browsing. For further information, see our Cookies Policy

Technical cookies

Used for the website’s proper functioning.

Customisation cookies

They retrieve information in order for the user to access the service with certain characteristics that may change their experience from that of other users. For example, the language selected or other options that allow for an improved accessibility within the website.

Analytics cookies

Third party (Google). These allow for follow-up and user behaviour analysis for the purpose of incorporating improvements to the website’s content.

Behavioural advertising cookies

Third party (Google). They store information on user behaviour obtained through ongoing observation of their browsing habits, allowing for the development of a specific profile for information content optimisation.

Home >
Inside information >
Inside information

Page 138 out of 141

from 31/01/2023 to 14/04/2026

- 21/02/2023
- 15:40
- MOBILIARIA MONESA, S.A. (MONESA)
- On suspensions, lifting of suspensions and delistings
- Generalitat de Catalunya´s resolution to initiate removal from trading proceedings, and to suspend trading on MOBILIARIA MONESA, S.A. with effect from market close on 23 February 2023.
- Register number: 1768
- 21/02/2023
- 08:14
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On corporate governance
- The Company informs about the agreements adopted by the Board of Directors.
- Register number: 1767
- 21/02/2023
- 08:08
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the presentation related to the 2022 full year financial results
- Register number: 1766
- 21/02/2023
- 08:06
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the press release related to the 2022 full year financial results
- Register number: 1765
- 21/02/2023
- 08:02
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the Integrated Report for the year 2022
- Register number: 1764
- 20/02/2023
- 18:48
- AMREST HOLDINGS, SE
- On P&L
- AmRest - Preliminary results Q4 2022
- Register number: 1763
- 20/02/2023
- 18:01
- ACS, ACTIVIDADES DE CONSTRUCCION Y SERVICIOS, S.A.
- On financial instruments
- Prórroga de un contrato forward sobre 11.968.007 acciones de ACS
- Register number: 1762
- 20/02/2023
- 06:52
- ALMIRALL, S.A.
- On P&L
- Presentation FY2022 Financial Results
- Register number: 1761
- 16/02/2023
- 09:31
- SACYR, S.A.
- On corporate transactions: mergers, acquisitions and others
- The company announces progress on the announced divestment plan.
- Register number: 1760
- - Related to communication no. 1595 dated 05/10/2022 (17:58)
- 16/02/2023
- 08:25
- PHARMA MAR, S.A.
- On business and financial situation
- The Company announces the closure of the Phase III “Neptuno” trial with plitidepsin for the treatment of COVID-19 in hospitalized patients.
- Register number: 1759

Page 138 out of 141